The Proline Cycle As a Potential Cancer Therapy Target

Area of Science:

• Biochemistry
• Cancer Biology
• Metabolic Pathways

Background:

• Emerging evidence highlights the role of proline metabolism in cancer.
• A novel proline metabolic cycle, involving Δ1-pyrroline-5-carboxylate (P5C), impacts cancer cell survival, proliferation, and metastasis.

Purpose of the Study:

• To detail the structures and reaction mechanisms of proline dehydrogenase (PRODH) and P5C reductase (PYCR).
• To elucidate the role of the proline-P5C cycle in cancer metabolism.
• To identify challenges and opportunities in targeting this pathway for cancer therapy.

Main Methods:

• Review of enzymatic structures and reaction mechanisms of PRODH and PYCR.
• Analysis of the proline-P5C cycle's involvement in cancer cell metabolic processes.
• Discussion of potential therapeutic strategies targeting proline metabolism.

Main Results:

• The proline-P5C cycle, formed by PRODH and PYCR, supports cancer cell ATP production, biosynthesis, anaplerosis, and redox balance.
• PRODH catalyzes proline oxidation, while PYCR reduces P5C to proline.
• GSALDH facilitates the conversion of GSAL to glutamate.

Conclusions:

• The proline-P5C cycle is a significant factor in cancer metabolism, influencing key cellular functions.
• Discovering specific inhibitors for PRODH and PYCR isoforms is critical for research and drug development.
• Targeting the proline-P5C cycle presents a promising strategy for novel cancer therapeutics.